RxDoctor Payments Data

Julie Balk

Family · Draper, UTNPI 1932239720

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.9% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $471, more than ten times the $46 reported in 2021.

$1,223in general payments, 2019–2025

Across 49 payments — averaging $24.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$131
  • Seagen Inc.$117
  • E.r. Squibb & Sons, L.L.C.$113
  • Gilead$112
  • Eisai Inc.$101
  • Exeltis, USA Inc.$97
  • plus $553 from 18 others

What the payments were for

  • Food & beverage$1,12492%
  • Education$998%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,223 in reported general payments places this provider in the 75th percentile of 1,460 family providers in Utah.

See all family providers in Utah →

Other family in Draper

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →